
# Title 37 - Patents, Trademarks, and Copyrights
## Chapter I - United States Patent and Trademark Office, Department of Commerce
### Subchapter A - General
#### PART 1 - RULES OF PRACTICE IN PATENT CASES
##### Subpart F - Adjustment and Extension of Patent Term
###### Extension of Patent Term Due to Regulatory Review
####### ยง 1.710 Patents subject to extension of the patent term.
######## product

(b) The termreferred to in paragraph (a) of this section means-

(1) The active ingredient of a new human drug, antibiotic drug, or human biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act) including any salt or ester of the active ingredient, as a single entity or in combination with another active ingredient; or

(2) The active ingredient of a new animal drug or veterinary biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Virus-Serum-Toxin Act) that is not primarily manufactured using recombinant DNA, recombinant RNA, hybridoma technology, or other processes including site specific genetic manipulation techniques, including any salt or ester of the active ingredient, as a single entity or in combination with another active ingredient; or

(3) Any medical device, food additive, or color additive subject to regulation under the Federal Food, Drug, and Cosmetic Act.
